Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
for
Solid Tumor, MET Alteration
Location: Canton OH, Washington D.C. DC, Nashville TN
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06669117
Phase 1, Phase 2, Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Location: Canton OH, Detroit MI, Fairfax VA, Durham NC,
Sponsor: Sairopa B.V.
Sex: All
Age: 18+
Code: NCT05856981
Phase 1, Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
for
Non-small Cell Lung Cancer
Location: Canton OH, Cleveland OH, Mayfield Heights OH,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase 2, Phase 3, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Canton OH, Strongsville OH, Independence OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
for
Primary Myelofibrosis (PMF),
Location: Canton OH, Houston TX, Glendale CA, Whittier CA
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04878003
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for
Advanced Melanoma
Location: Canton OH, Pittsburgh PA, Toronto, Bethesda MD,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT06697301
Phase 2, Phase 3, Recruiting
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
Location: Canton OH, Maumee OH, Grand Rapids MI, York PA,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
for
Primary Myelofibrosis (PMF),
Location: Canton OH, Chicago IL, Milwaukee WI, New York NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03662126
Phase 2, Phase 3, Recruiting
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Canton OH, Cleveland OH, Detroit MI, Nasville TN,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT06228326
Phase 1, Phase 2, Recruiting
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Canton OH, Cleveland OH, Pittsburgh PA, Columbus OH,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase 1, Phase 2, Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Location: Canton OH, Brampton, Fairfax VA, Milwaukee WI,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05967689
Phase 2, Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Canton OH, Pittsburgh PA, Columbus OH, Fairfax VA,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
for
Triple Negative Breast Cancer
Location: Canton OH, Columbus GA, Springfield MO
Sponsor: Jina Pharmaceuticals Inc.
Sex: Female
Age: 18 - 65
Code: NCT03671044
Phase 3, Recruiting
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Canton OH, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
for
Metastatic Pancreatic Adenocarcinoma
Location: Canton OH, Tampa FL, Whittier CA
Sponsor: Eleison Pharmaceuticals LLC.
Sex: All
Age: 18+
Code: NCT01954992
Phase 3, Recruiting
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection